Explore our news bulletins and archive
for the latest press coverage, as well as articles of interest.

1st Circuit Revives Loestrin Pay-For-Delay Suit

Warner Chilcott will have to face claims it paid drugmakers to delay producing a generic version of its contraceptive Loestrin in multidistrict litigation after the First Circuit on Monday found that noncash settlements can be subject to antitrust scrutiny.